Applied Statistics

Profile Details
Ian Tannock
Affiliations:

University of Toronto

Princess Margaret Hospital

 
M5G 2M9.
Toronto ON, Canada
Phone:
Fax:
My Blogs:
 
Age:
Bio:
 
Specialty:
Oncology
 
Presented at Events Covering:
Biology, Biotechnology, Cancer Biology, Cataract & Refractive Surgery, Cell Biology, Epidemiology, Genomics, Hematology, Hepatology, Leukemia, Molecular Biology, Neuroscience, Oncology, Stem Cells, Translational Research, Urology
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 19 / 3501 (What's this?)
Accomplish Score: 6640
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 373
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 228 (2966 / 0)
 
Honors and Awards: 40 (400 / 0)
  • Division of Medical Oncology, Education Award (2014)
  • Member, Order of Canada (2013)
  • ESMO Award (2012)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 44 (396 / 0)
  • A Phase III international trial (U.S.A., Australia, Canada) of cisplatin alone or in combination with doxorubicin, vinblastine, and methotrexate in advanced bladder cancer (2015)
  • Phase I-II Study of M-VAC plus radiotherapy for locally advanced carcinoma of the bladder (2015)
  • Clinical trial of pre-operative (or radical) radiotherapy with randomized addition of concurrent cisplatin for locally advanced transitional cell carcinoma of the bladder (2015)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 15 (105 / 0)
  • Journal of the National Cancer Institute (2000 - 2014)
  • Radiotherapy and Oncology (1991 - 2014)
  • British Journal of Cancer (1990 - 2011)
 
Peer Reviewed Papers, Books, Chapters: 375 (2250 / 0)
  • Words of wisdom. Re: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing (2014)
  • Neutrophil to lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials (2014)
  • Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis (2014)
 
Pre/Non Reviewed Papers, Proceedings: 81 (324 / 0)
  • The Basic Science of Oncology. (2013)
  • Discovery and evaluation of anticancer drugs. (2013)
  • Introduction to Cancer Biology (2013)
 
Membership in Professional Societies: 66 (198 / 0)
  • Swiss Cancer Trials Organization (SAKK) (2014 - 2015)
  • IPSEN (2014)
  • Royal Marsden Hospital/Institute of Cancer Research (2014)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 1

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.